RxDoctor Payments DataLook up a doctor →

ZEPZELCA: payments to doctors

Payments that named ZEPZELCA as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$7M
Providers
8,002
Transactions
25,346
Average per transaction
$274

The per-transaction average — $274 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,002 providers the average total is $869, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
JAZZ Pharmaceuticals Inc.$6,351,87791.4%
Jazz Pharmaceuticals Inc.$600,6158.6%
← All drugs & devices